The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood
- PMID: 21823914
- PMCID: PMC3157746
- DOI: 10.1089/cap.2010.0074
The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood
Abstract
Objective: To examine late adolescent substance use outcomes in relation to childhood conduct disorder (CD) and psychostimulant treatment in urban youth found to have attention-deficit/hyperactivity disorder (ADHD) in childhood.
Methods: Ninety-seven adolescents, evaluated during childhood, were seen for follow-up on average 9.30 (SD = 1.65) years later along with a well-matched never-ADHD control group. Stimulant treatment history was coded: Never (n = 28), up to 1 year (n = 19), 1 to 5 years (n = 28), and greater than 5 years (n = 22). Substance use at outcome was coded dimensionally for severity (frequency × intensity) and categorically for substance use disorders (SUDs).
Results: Individuals with ADHD+CD in childhood had significantly higher rates of SUD and substance use severity than those with childhood ADHD and controls. The ADHD and control groups did not differ significantly. Among those with childhood ADHD, there were no significant differences in SUD status or substance use severity as a function of medication history.
Conclusions: Within an ethnically diverse urban sample, the increased rate of substance use associated with ADHD was fully accounted for by the presence of CD. These results extend previous findings indicating little impact of psychostimulant treatment on later substance use to an ethnically diverse urban sample and to individuals who received treatment for up to 12 years.
Figures


Similar articles
-
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014. Epub 2013 Feb 8. J Am Acad Child Adolesc Psychiatry. 2013. PMID: 23452682 Free PMC article. Clinical Trial.
-
ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.Addict Behav. 2014 Jan;39(1):325-8. doi: 10.1016/j.addbeh.2013.09.002. Epub 2013 Sep 10. Addict Behav. 2014. PMID: 24090624
-
Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.Arch Pediatr Adolesc Med. 2008 Oct;162(10):916-21. doi: 10.1001/archpedi.162.10.916. Arch Pediatr Adolesc Med. 2008. PMID: 18838643 Free PMC article.
-
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908x280707. Epub 2008 Apr 1. Curr Med Res Opin. 2008. PMID: 18384709 Review.
-
Attention deficit hyperactivity disorder and substance use disorders.Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):309-23, viii. doi: 10.1016/j.chc.2007.11.003. Child Adolesc Psychiatr Clin N Am. 2008. PMID: 18295148 Review.
Cited by
-
Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence.Neurosci Biobehav Rev. 2022 Apr;135:104575. doi: 10.1016/j.neubiorev.2022.104575. Epub 2022 Feb 10. Neurosci Biobehav Rev. 2022. PMID: 35151770 Free PMC article. Review.
-
Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.J Subst Abuse Treat. 2013 Feb;44(2):224-30. doi: 10.1016/j.jsat.2012.07.001. Epub 2012 Aug 11. J Subst Abuse Treat. 2013. PMID: 22889694 Free PMC article. Clinical Trial.
-
The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.J Child Adolesc Psychopharmacol. 2022 May;32(4):200-214. doi: 10.1089/cap.2022.0016. Epub 2022 May 4. J Child Adolesc Psychopharmacol. 2022. PMID: 35587209 Free PMC article.
-
Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency.Addiction. 2015 May;110(5):784-95. doi: 10.1111/add.12880. Epub 2015 Mar 24. Addiction. 2015. PMID: 25664657 Free PMC article. Clinical Trial.
-
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014. Epub 2013 Feb 8. J Am Acad Child Adolesc Psychiatry. 2013. PMID: 23452682 Free PMC article. Clinical Trial.
References
-
- Andersen SL. Arvanitogiannis A. Pliakas AM. LeBlanc C. Carlezon WA., Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci. 2002;5:13–14. - PubMed
-
- Anglin MD. Booth MW. Ryan TM. Hser YI. Ethnic differences in narcotics addiction. II. Chicano and Anglo addiction career patterns. Int J Addict. 1988;23:1011–1027. - PubMed
-
- Barkley RA. Fischer M. Edelbrock CS. Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. 1990;29:546–557. - PubMed
-
- Barkley RA. Fischer M. Smallish L. Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics. 2003;111:97–109. - PubMed
-
- Biederman J. Monuteaux MC. Spencer T. Wilens TE. Macpherson HA. Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165:597–603. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical